Shire (SHPGY)

84.41 -1.70  -1.97%  May 31, 5:21PM Go Pro
Watch this stock
View Full Chart SHPGY Price Chart

Key Stats

Market Cap 15.83B
Revenue Growth 20.53%
Profit Margin 20.34%
Earnings Yield 1.84%
Dividend Yield 0.92%
Earnings Per Share TTM 1.553
PE Ratio 54.35
Price / Sales Ratio 3.546
52 Week High 108.79
52 Week Low 85.60
Beta 0.7547
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

5:07PM Health Care Sector Wrap Fox Business
4:40PM Is it Time to Buy 2012's Worst Biotechs? Fool
May 30 Health Care Sector Wrap Fox Business
May 29 [$$] FDA Warns About Fakes of ADHD Drug Adderall
May 29 Is Chelsea A Bad News Buy?
May 29 Is Chelsea A Bad News Buy? Fool
May 25 Goldman Sachs Says Buy Shire plc (SHPGY) On Recent Weakness, Keeps Top Rating Street Insider
May 24 Shire Presents Data on Venvanse
May 24 SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
May 23 $SHPGY amended latest Quarterly Report http://stks.co/3wqa by MarketBrief
May 09 $SHPGY filed latest Quarterly Report http://stks.co/3kVR by MarketBrief
Apr 23 HIGH $CALL VOLU $HAS 1360% $GFI 991% $ABV 778% $SHPGY 713% $CLX 691% $ARMH 570% $BKS 534% $IRM 533% $VOD 494% $ASH 415% by livevol_pro
Apr 23 HIGH $CALL VOLU $HAS 1147% $GFI 986% $ABV 757% $SHPGY 713% $CLX 683% $BKS 501% $VOD 404% $IRM 402% $XCO 391% $INFY 384% by livevol_pro
Apr 23 HIGH $CALL VOLU $HAS 1041% $ABV 733% $SHPGY 697% $CLX 672% $GFI 658% $INFY 368% $XCO 362% $BKS 324% $IACI 304% $VOD 302% by livevol_pro

Profile

Exchange: NASDAQGS       Sector: Healthcare       Industry: Biotechnology

Shire Plc is a rapidly growing global specialty biopharmaceutical company. It engages in the research and development, manufacture, sale, and distribution of pharmaceutical products. It operates in two segments, Specialty Pharmaceuticals and Human Genetic Therapies. Originating in and with a large operational base in the United Kingdom, its brands and products include Adderall XR, Carbatrol, Fosrenol, and the recently released Vyvanse. The company markets its products through distributors in North America, the Republic of Ireland, the United Kingdom, and internationally. It has collaboration agreements with Santaris Pharma A/S, Renovo Limited, and Acceleron Pharma, Inc. Shire plc was founded in 1986 and is based in Dublin, Ireland.

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Shire is down 11.30% over the last year vs S&P 500 Total Return up 0.88%, Sangamo BioSciences down 37.46%, and Protalix BioTherapeutics up 3.55%.

  • SHPGY Total Returns
  • ^SPXTR Total Returns
  • SGMO Total Returns
  • PLX Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Cash Flow Statement View Statement

Get Quote for

Pro Strategies Featuring SHPGY

Did Shire make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

SHPGY Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
SHPGY 84.41 -1.70 -1.97% 16.15B
SHP 6.43 +0.05 +0.78% 119.11M
SHOR 4.19 +0.17 +4.23% 193.64M
SHOO 40.48 -0.09 -0.22% 1.785B
SHO 10.00 +0.20 +1.99% 1.168B
SHLO 10.10 +0.26 +2.64% 165.71M
SHLM 21.36 -0.32 -1.48% 637.61M
SHLD 49.62 -2.72 -5.20% 5.569B
SHIP 2.29 -0.02 -0.87% 27.39M
SHI 28.65 -0.35 -1.21% 884.50M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close